The Role of the Complement System in Paroxysmal Nocturnal Hemoglobinuria (PNH)
Webinar Recorded on Oct. 6, 2020
Sponsored by Apellis Pharmaceuticals, Inc.
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired hematologic disease. PNH is characterized by complement-mediated hemolysis, leading to severe anemia and other debilitating symptoms. Patients are at risk of fatal disease complications, including thrombotic and hemorrhagic events. While current therapies are available, substantial unmet needs remain.
Join expert faculty for an overview of PNH pathophysiology, diagnosis, and the current challenges of adequately treating patients.
Topics covered include:
- Overview of the complement system, part of the innate immune response system
- The PNH patient journey, including the long path to diagnosis
- Guidelines and tools for recognizing and diagnosing PNH
- Current PNH therapy options and guidelines
- Remaining unmet need despite current therapies, including clinical symptoms
- Jamile M. Shammo, MD, FASCP, FACP
Professor of Medicine and Pathology
Head of the MDS/MPN/Bone Marrow Failure Program
Rush University Medical Center
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.